Top Markets
#1 Purr Purr +32.88%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +32.33%
#3 OriginTrail OriginTrail +22.45%
#4 ApeX ApeX +19.17%
#5 UnifAI Network UnifAI Network +18.04%
#6 Unit Plasma Unit Plasma +17.45%
#7 Plasma Plasma +17.45%
#8 Morpho Morpho +16.16%
#9 Pendle Pendle +15.57%
#10 Non-Playable Coin Non-Playable Coin +15.38%
Coin of the day
Purr Purr
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Sudarshan Pharma Industries Ltd. Sudarshan Pharma Industries Ltd.

Sudarshan Pharma Industries Ltd.

SUDARSHAN
Rang in aandelen #21543
Sudarshan Pharma Industries Ltd. operates as a supplier of specialty chemicals,... Sudarshan Pharma Industries Ltd. operates as a supplier of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company strategically sources its products externally to cater to clients both within India and internationally. Additionally, the firm is active in contract manufacturing and provides outsourced generic pharmaceutical formulations and various medicines. These are supplied to a broad spectrum of clients, including healthcare institutions, governmental agencies, non-profit organizations, and hospitals. Established on July 23, 2008, Sudarshan Pharma maintains its corporate headquarters in Mumbai, India.
Aandeelprijs
$0.42123944
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$105.17M
Verandering (1 dag)
-0.57%
Verandering (1 jaar)
5.80%
Land
IN
Handel Sudarshan Pharma Industries Ltd. (SUDARSHAN)

Categorie

Healthcare
Winst voor Sudarshan Pharma Industries Ltd. (SUDARSHAN)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Sudarshan Pharma Industries Ltd. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Sudarshan Pharma Industries Ltd. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT